Related Experiment Video

Updated: Aug 14, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?

Mehmet Uzunlulu1, Aytekin Oğuz, Kürşat Tigen

  • 1Department of Internal Medicine, SSK Göztepe Training Hospital, 34732, Istanbul, Turkey. mehmetuzunlulu@yahoo.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|December 7, 2005
PubMed

Insights

Turkish individuals with coronary artery disease (CAD) have lower high-density lipoprotein (HDL) cholesterol levels. However, overall HDL cholesterol in this population was not as low as previously suggested by epidemiological studies.

Area of Science:

  • Cardiology
  • Epidemiology
  • Biochemistry

Background:

  • Epidemiological data indicate lower high-density lipoprotein (HDL) cholesterol in Turkish populations compared to global averages.
  • HDL cholesterol is a critical marker for cardiovascular health.

Purpose of the Study:

  • To investigate HDL cholesterol levels in Turkish individuals with and without coronary artery disease (CAD).
  • To determine if HDL cholesterol levels in this cohort align with previously reported lower levels.

Main Methods:

  • A cohort of 420 patients (age >= 40) undergoing coronary angiography was analyzed.
  • Patients were categorized into coronary artery disease (CAD) and non-CAD groups based on angiography results.
  • Exclusion criteria included use of fibric acid derivatives or niacin.

Main Results:

  • Patients with CAD exhibited lower average HDL cholesterol levels (45.0+/-10.5 mg/dl) compared to those without CAD (47.7+/-9.0 mg/dl).
  • A statistically significant difference (p<0.05) was observed between the CAD and non-CAD groups.
  • HDL cholesterol levels, while lower in the CAD group, were not as critically low as anticipated from prior epidemiological findings.

Conclusions:

  • Coronary artery disease is associated with reduced HDL cholesterol levels in the studied Turkish population.
  • The findings suggest that while HDL cholesterol is lower in Turkish CAD patients, it may not be as diminished as previously estimated.
  • Further research is warranted to understand the specific factors influencing HDL cholesterol in this demographic.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...